Lactulose and Glucose Breath Tests as Predictors of Clinical Benefit From Rifaximin in Irritable Bowel Syndrome
Clinical trial NCT01803724 · UNKNOWN
Trial details
- NCT number
- NCT01803724
- Sponsor
- Pontificia Universidad Catolica de Chile
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2013-05-01
- Primary completion
- 2014-06-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.